Literature DB >> 47363

Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli.

T J Sullivan, K L Parker, W Stenson, C W Parker.   

Abstract

The cyclic adenosine 3', 5'-monophosphate (cAMP) content of isolated unstimulated mast cells and the changes induced by a variety of pharmacologic, metabolic, and physical stimuli were studied. A modified bovine serum albumin density gradient purification method consistently provided mast cell preparations which were 95% or more pure, without apparent damage, and a 73% recovery of the mast cells applied to the gradients. The measured cAMP in unstimulated mast cells was high, a mean of 16 picomoles per million cells. Moderate agitation or contact with glass increased cAMP content about 2-fold. When calcium was omitted from the medium mast cell cAMP was markedly elevated; incremental increases in added calcium ion concentration from 1 muM to 1 mM caused a linear decrease in cAMP content. Theophylline (3 to 20 mM) caused a dose-related increase in mast cell cAMP content, approximately 2-fold at 20 mM theophylline. Epinephrine (0.01 to 1 mM) caused a modest, dose-related increase in cAMP. In the presence of theophylline, epinephrine increased cAMP levels equal to or greater than the sum of the effects of the agents used individually. The increase in cAMP induced by epinephrine was completely inhibited by 100 muM propranolol and partially inhibited by 10 muM propranolol, thus suggesting that a beta adrenergic receptor is involved. Prostaglandin E1 (PGE1) and histamine (in the presence of theophylline) also raised cAMP. Carbamylcholine (1 nM) lowered cAMP 38%; Atropine (0.1 mM) inhibited the decrease in cAMP induced by 1 nM carbamylcholine by 83% indicating that a muscarinic receptor is involved. In these homogeneous single cell suspensions, therefore, cholinergic and beta adrenergic agents have opposing effects on cAMP levels. Diazoxide (10 muM) and adenine (1 muM) caused 37 and 32% decreases in cAMP, respectively. The availability of highly purified mast cells and the identification of agents which either decrease or increase cAMP content allows a direct examination of the role of cAMP in histamine release.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47363

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.

Authors:  Y Kosaka; H Kawabe; A Ishii
Journal:  Agents Actions       Date:  1987-06

2.  Histamine release from nasal mucosal mast cells in patients with chronic hypertrophic non-allergic rhinitis, after parasympathetic nerve stimulation.

Authors:  L Rucci; E Masini; M B Cirri Borghi; E Giannella; P F Mannaioni
Journal:  Agents Actions       Date:  1988-12

3.  Does perioperative prostaglandin E1 affect survival of patients with esophageal cancer?

Authors:  Fahimeh Farrokhnia; Jalil Makarem; Habibollah Mahmoodzadeh; Nazanin Andalib
Journal:  World J Gastrointest Surg       Date:  2012-12-27

4.  Immunologically induced pleural and peritoneal mast cell histamine release: difference in responsiveness in relation to secretagogue and rat strain used.

Authors:  H Bergstrand; I Andersson; A Björnsson; I M Frick; B Lundquist; R Pauwels
Journal:  Agents Actions       Date:  1984-10

Review 5.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09

6.  Characteristics of histamine release evoked by acetylcholine in isolated rat mast cells.

Authors:  P Blandina; R Fantozzi; P F Mannaioni; E Masini
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

7.  Stimulation by alcohols of cyclic AMP metabolism in human leukocytes. Possible role of cyclic AMP in the anti-inflammatory effects of ethanol.

Authors:  J P Atkinson; T J Sullivan; J P Kelly; C W Parker
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

8.  Correlation between cholinergic histamine release and quinuclidinyl-benzilate ([3H]-QNB) binding in mast cell membranes.

Authors:  E Masini; P Blandina; R Fantozzi; S Brunelleschi; P F Mannaioni
Journal:  Agents Actions       Date:  1981-04

9.  What - if any - is the role of adrenergic mechanisms in histamine release from mast cells?

Authors:  P E Alm; G D Bloom
Journal:  Agents Actions       Date:  1981-04

10.  Histamine release from rat mast cells induced by protamine sulfate and polyethylene imine.

Authors:  S Schnitzler; H Renner; U Pfüller
Journal:  Agents Actions       Date:  1981-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.